Found: 320
Select item for more details and to access through your institution.
Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn's disease
- Published in:
- 2021
- By:
- Publication type:
- Letter
Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting.
- Published in:
- Journal of Digestive Diseases, 2017, v. 18, n. 10, p. 566, doi. 10.1111/1751-2980.12539
- By:
- Publication type:
- Article
Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
- Published in:
- Journal of Digestive Diseases, 2016, v. 17, n. 6, p. 383, doi. 10.1111/1751-2980.12356
- By:
- Publication type:
- Article
PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 6, p. 1276, doi. 10.3390/ijms18061276
- By:
- Publication type:
- Article
Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries.
- Published in:
- BMC Health Services Research, 2022, v. 22, p. 1, doi. 10.1186/s12913-022-08683-y
- By:
- Publication type:
- Article
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.
- Published in:
- 2014
- By:
- Publication type:
- journal article
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 9, p. 3863, doi. 10.1172/JCI72189
- By:
- Publication type:
- Article
The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 3, p. 377, doi. 10.3390/jcm10030377
- By:
- Publication type:
- Article
Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3533, doi. 10.3390/jcm9113533
- By:
- Publication type:
- Article
Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2905, doi. 10.3390/jcm9092905
- By:
- Publication type:
- Article
Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2697, doi. 10.3390/jcm9092697
- By:
- Publication type:
- Article
Early Intervention in Ulcerative Colitis: Ready for Prime Time?
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2646, doi. 10.3390/jcm9082646
- By:
- Publication type:
- Article
Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2350, doi. 10.3390/jcm9082350
- By:
- Publication type:
- Article
Thiopurines' Metabolites and Drug Toxicity: A Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2216, doi. 10.3390/jcm9072216
- By:
- Publication type:
- Article
Which MRI Score and Technique Should Be Used for Assessing Crohn's Disease Activity?
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1691, doi. 10.3390/jcm9061691
- By:
- Publication type:
- Article
Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1536, doi. 10.3390/jcm9051536
- By:
- Publication type:
- Article
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1002629
- By:
- Publication type:
- Article
Network Meta‐Analysis: Histologic and Histo‐Endoscopic Improvement and Remission With Advanced Therapy in Ulcerative Colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1276, doi. 10.1111/apt.18315
- By:
- Publication type:
- Article
Review article: Measuring disease severity in inflammatory bowel disease – Beyond treat to target.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 9, p. 1176, doi. 10.1111/apt.18231
- By:
- Publication type:
- Article
Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 686, doi. 10.1111/apt.18194
- By:
- Publication type:
- Article
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 5, p. 563, doi. 10.1111/apt.18158
- By:
- Publication type:
- Article
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long‐term extension period of STARDUST.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 175, doi. 10.1111/apt.17751
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 8, p. 740, doi. 10.1111/apt.17666
- By:
- Publication type:
- Article
Review article: Externally derived control arms—An opportunity for clinical trials in inflammatory bowel disease?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 7, p. 659, doi. 10.1111/apt.17684
- By:
- Publication type:
- Article
A randomised, double‐blind, placebo‐controlled study of the LAG‐3‐depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 3, p. 283, doi. 10.1111/apt.17557
- By:
- Publication type:
- Article
Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 11, p. 1231, doi. 10.1111/apt.17509
- By:
- Publication type:
- Article
Editorial: risankizumab – ready to break ceilings? author's reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 5, p. 486, doi. 10.1111/apt.17261
- By:
- Publication type:
- Article
Effect of risankizumab on health‐related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 5, p. 496, doi. 10.1111/apt.17242
- By:
- Publication type:
- Article
Editorial: shedding new light on extraintestinal manifestations in inflammatory bowel disease.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Letter: treatment with subcutaneous CT‐P13 in Crohn's disease patients with intravenous infliximab failure.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 4, p. 508, doi. 10.1111/apt.16770
- By:
- Publication type:
- Article
Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 4, p. 446, doi. 10.1111/apt.16700
- By:
- Publication type:
- Article
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 7, p. 944, doi. 10.1111/apt.16544
- By:
- Publication type:
- Article
Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 3, p. 312, doi. 10.1111/apt.16463
- By:
- Publication type:
- Article
Determinants of IBD‐related disability: a cross‐sectional survey from the GETAID.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 10, p. 1098, doi. 10.1111/apt.16353
- By:
- Publication type:
- Article
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 7, p. 784, doi. 10.1111/apt.16248
- By:
- Publication type:
- Article
Confounding and bias in observational studies in inflammatory bowel disease: a meta‐epidemiological study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 6, p. 712, doi. 10.1111/apt.16222
- By:
- Publication type:
- Article
Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 3, p. 400, doi. 10.1111/apt.16176
- By:
- Publication type:
- Article
Editorial: diagnostic precision of iron deficiency in inflammatory bowel disease. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 401, doi. 10.1111/apt.15832
- By:
- Publication type:
- Article
Identification of circulating biomarkers of Crohn's disease and spondyloarthritis using Fourier transform infrared spectroscopy.
- Published in:
- Journal of Biophotonics, 2023, v. 16, n. 2, p. 1, doi. 10.1002/jbio.202200200
- By:
- Publication type:
- Article
Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study.
- Published in:
- Gastroenterology Research & Practice, 2020, p. 1, doi. 10.1155/2020/4060648
- By:
- Publication type:
- Article
Rôles du facteur von Willebrand dans les maladies inflammatoires chroniques de l'intestin.
- Published in:
- Sang Thrombose Vaisseaux, 2024, v. 36, n. 4, p. 159, doi. 10.1684/stv.2024.1293
- By:
- Publication type:
- Article
Le méthotrexate, le grand oublié des MICI.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
MICI et obésité : le cercle vicieux.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 1, p. 33, doi. 10.1684/hpg.2023.2697
- By:
- Publication type:
- Article
Quelle place pour la médecine holistique dans les maladies inflammatoires chroniques intestinales ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 9, p. 931, doi. 10.1684/hpg.2023.2668
- By:
- Publication type:
- Article
Le bon traitement pour le bon patient.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe.
- Published in:
- BMC Gastroenterology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12876-021-02028-5
- By:
- Publication type:
- Article